I am a
Home I AM A Search Login

Papers of the Week


Papers: 24 Jul 2021 - 30 Jul 2021


Animal Studies, Pharmacology/Drug Development


2021 Sep


J Pharmacol Sci


147


1

Ibudilast suppresses oxaliplatin-induced mechanical allodynia and neurodegeneration in rats.

Authors

Egashira N, Goto Y, Takahashi R, Iba H, Yamamoto S, Watanabe T, Kubota K, Kawashiri T, Taniguchi C, Katsurabayashi S, Iwasaki K
J Pharmacol Sci. 2021 Sep; 147(1):114-117.
PMID: 34294361.

Abstract

Oxaliplatin is a key drug used in the management of solid tumors, such as colorectal cancer; however, it causes peripheral neuropathy. In this study, we investigated the effect of ibudilast, a phosphodiesterase inhibitor, on oxaliplatin-induced mechanical allodynia and histological changes in rats. Ibudilast (7.5 mg/kg, i.p., 5 times per week) reduced mechanical allodynia and histological changes induced by oxaliplatin (4 mg/kg, i.p., twice a week). In contrast, ibudilast (0.01-10 μM) had no effect on oxaliplatin-induced tumor cytotoxicity in murine colon adenocarcinoma 26 cells. These findings suggest that ibudilast could be useful for preventing oxaliplatin-induced peripheral neuropathy in clinical settings.